Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-18
1998-09-29
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514473, 514912, 549475, 549497, A61K 3134
Patent
active
058146601
ABSTRACT:
Substituted tetrahydrofuran analogs of prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed.
REFERENCES:
patent: 3883659 (1975-05-01), Vlattas
patent: 4088779 (1978-05-01), Vlattas
patent: 4133817 (1979-01-01), Lourens et al.
patent: 4133948 (1979-01-01), Lourens et al.
patent: 4599353 (1986-07-01), Bito et al.
patent: 5321128 (1994-06-01), Stjernschantz et al.
patent: 5574066 (1996-11-01), Chan et al.
Alm, "The Potential of Prostaglandin Derivatives in Glaucoma Therapy" Current Opinion in Ophthalmology 4(11):44-50 (1993).
Arndt et al., "Stereospecific Synthesis of Modified Prostaglandins Derived from Carbohydrates. Part 1." S. Afr. J. Chem. 34(4):121-127 (Jun. 1981).
Bock, et al. "Acid Catalyzed Dehydratin of Alditols. Part I. .sub.D -Glucitol and .sub.D -Mannitol" Acta Chemica Scandinavica B 35:441-449 (1981).
Giuffre, "The Effects of Prostaglandin F.sub.2.alpha. the Human Eye" Graefe's Arch Clin Exp Ophthalmol 222:139-141 (1985).
Hanessian et al., "Total Synthesis of 11-Oxaprostaglandin F.sub.2.alpha. and F.sub.2.beta." Carbohydrate Research 141(2):221-238 XP000644751 (1985).
Kerstetter et al., "Prostaglandin F.sub.2.alpha. -1-Isopropylester Lowers Intraocular Pressure Without Decreasing Aqueous Humor Flow" American Journal of Ophthalmology 105:30-34 (1988).
Thierauch et al., "Prostaglandins and Their Receptors: II. Receptor Structure and Signal Transduction" Journal of Hypertension 12:1-5 (1994).
Verdoorn et al., "Synthesis of Methyl(5Z,13E(15S)-9.alpha.-acetoxy-15-hydroxy-17-(3-trifluoromethylphenyl )-11-oxa-18,19,20-trinorprosta-5,13-dienoate" S. Afr. Tydskr. Chem. 40(2):134-138 XP000618452 (1987).
Vlattas et al., "Synthesis of 9-Oxaprostaglandins" Tetrahedron Letters No. 51/52:4455-4458, Pergamon Press, 1974.
Vlattas et al., "Synthesis of 11-oxaprostaglandins" Tetrahedron Letters No. 51/52:4451-4454, XP000644759, Pergamon Press, 1974.
Alcon Laboratories Inc.
Copeland Barry L.
Owens Amelia
LandOfFree
9-oxa prostaglandin analogs as ocular hypotensives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 9-oxa prostaglandin analogs as ocular hypotensives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 9-oxa prostaglandin analogs as ocular hypotensives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686738